FindTrial
Sign In

Clinical research of flupentixol-melitracen and mesalazine on ulcerative colitis

Clinical research of flupentixol-melitracen and mesalazine on ulcerative colitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016438
Enrollment
Unknown
Registered
2018-06-01
Start date
2018-06-30
Completion date
Unknown
Last updated
2018-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

control:mesalazine 1 po qid
observation group:mesalazine 1 po qid
flupentixol-melitracen 1pill po tid

Sponsors

Guiyang 1st People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 75 Years

Inclusion criteria

Inclusion criteria: ???????????(DAI 3-10?)????????3-10?(HADS0-7?)

Exclusion criteria

Exclusion criteria: UC patients with Severe activity (DAI 11-12 point) OR without Severe anxiety/depression (HADS 0 -7 point) will be excluded.

Design outcomes

Primary

MeasureTime frame
EFFECT OF TREATMENT;DAI;HADS;—

Countries

China

Contacts

Public ContactZHOU XIAOQIAN

Guiyang 1st People's Hospital

zhouzhai123154026@163.com+86 13765127272

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026